Elsevier is Improving Quality, Efficiency of Healthcare With "Smart Content" for Next-Generation Clinical Decision Support

Enriching and Providing Unprecedented Levels of Access to Content Can Drive Smarter Healthcare Applications, Improve Data Delivery, Increase Efficiency and Enhance Patient Care Quality

PHILADELPHIA, February 17, 2011 - To improve healthcare quality while reducing costs, Elsevier
(www.elsevier.com/), a global leader in medical and health
information, will unveil the next generation of clinical decision support
(CDS) featuring Smart Content at the annual meeting of the Healthcare
Information and Management Systems Society (HIMSS), Feb. 20-24, 2011, in
Orlando, Fla.

While fragmented information systems, poor communication and high costs
still plague healthcare, Elsevier's world-class information and point-of-care
technology solutions optimize decisions and actions to improve the overall
quality, safety and cost-effectiveness of care. Smart Content - medical
research, knowledge, education and data optimized for greater usability by
providers and payers- will improve care quality and safety even further.

"Advancing healthcare quality begins with providing clinicians with the
best, most current evidence-based information wherever and whenever it is
needed," said Michael Hansen, CEO, Elsevier Health Sciences. "Providing
unprecedented levels of access to our rich content assets will lead to better
decision-making and ultimately to better, more effective and efficient
patient care."

Providers and payers are working hard to respond to the national push to
form accountable care organizations and to qualify for meaningful use
incentives. Elsevier Clinical Decision Support (CDS) (
www.clinicaldecisionsupport.com/) supports those efforts by delivering
actionable clinical content, care planning and documentation, drug reference
and decision support, learning and performance management, data mining and
analytic solutions for provider, pharmacy and payer organizations - all of
which is enhanced through the innovation of Smart Content.

"Smart Content affects clinicians across the healthcare spectrum by
ensuring that evidence-based information is delivered in a clear, actionable
form that is tailored to the task at hand," explained Jonathan Teich, M.D.,
Ph.D., and Chief Medical Informatics Officer for Elsevier. "We are making
significant investments in new technologies and methods to re-engineer the
way that knowledge is stored, mapped and delivered for ever-greater precision
and impact. This new generation of clinical decision support will enhance the
value of the electronic health record, point-of-care reference, enterprise
analytics and other aspects of the digital healthcare workflow."

Special Analyst-Media Event

In addition to presentations and demonstrations at the Elsevier booth
(#2541), analysts and media at HIMSS will learn more about how 'Smart Content
Drives Smart Applications - The Future of Using Knowledge in Healthcare,' at
a special Breakfast Briefing on Tuesday, Feb. 22. Elsevier will demonstrate
how the next generation of CDS will improve quality, safety and efficiency,
enhancing how data and evidence that is selected and delivered to clinicians
will help clinicians produce better, faster diagnoses and more effective
treatments. RSVP online here:
surveys.himss.org/checkbox/Survey.aspx?surveyid=5323.

For more information about Elsevier CDS at HIMSS, visit
www.ClinicalDecisionSupport.com/HIMSS11 or stop by the Elsevier CDS
booth at HIMSS11, Booth #2541.

About Elsevier Clinical Decision Support

Elsevier Clinical Decision Support (
www.clinicaldecisionsupport.com/), a division of Elsevier, the global
leader in medical and health information, provides world class information
and point-of-care technology solutions that optimize decisions and actions to
improve the overall quality, safety and cost-effectiveness of care. The
business delivers on this promise through actionable clinical content, care
planning and documentation, drug reference and decision support, learning and
performance management, and data mining and outcomes analytics solutions for
provider, pharmacy and payer organizations.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com) and Cell
(www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (www.sciencedirect.com), SciVerse Scopus
(www.scopus.com), Reaxys (www.reaxys.com), MD Consult
(www.mdconsult.com) and Nursing Consult (www.nursingconsult.com
), which enhance the productivity of science and health professionals, and
the SciVal suite (www.scival.com) and MEDai's Pinpoint Review
(www.medai.com), which help research and health care institutions
deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact

    Tom Reller
    VP, Global Corporate Relations
    +1-215-239-3508
    T.Reller@elsevier.com

Media Contact: Tom Reller, VP, Global Corporate Relations, +1-215-239-3508, T.Reller at elsevier.com